Drugmaker GlaxoSmithKline has announced that it will, beginning in February 2009, publicly report grants provided to U.S. healthcare organizations.
The report, according to a news release, will be issued quarterly and will include grants given to hospitals, teaching institutions, managed-care organizations, professional associations, patient advocacy groups and continuing-medical-education companies. The report will include the name of the recipient, a short description of the grant and the amount, said Glaxo spokeswoman Sarah Alspach. The quarterly disclosures will not, however, include information on Glaxos consulting agreements with medical providers, Alspach said.
The pharmaceutical companys move comes at a time when state and federal officials are pushing for laws that require disclosure of such relationships between medical-products companies and healthcare providers. Massachusetts, for example, recently passed a disclosure requirement mandating drug companies and devicemakers to report payments of more than $50 made to medical providers while Iowa GOP Sen. Chuck Grassley (R-Iowa), ranking member of the Senate Finance Committee, is sponsoring a federal bill with similar requirements. -- by Shawn Rhea